Lower prescription drug costs by empowering Medicare to negotiate drug prices
Stated position. What this official has said they believe on this issue — a sourced claim, shown distinctly from any assessment of what they did. It is never scored and never affects the Integrity Score.
Derived from a tracked promise: “Lower prescription drug costs by empowering Medicare to negotiate drug prices”
Sources
“The savings, which take effect Jan. 1, are expected to lower enrollees' out-of-pocket spending by an estimated $1.5 billion in 2026.”
- U.S. Senate Roll Call Vote 117-2-325· archivedhttps://www.senate.gov/legislative/LIS/roll_call_votes/vote1172/vote_117_2_00325.htm ↗
“A bill to provide for reconciliation pursuant to title II of S. Con. Res. 14... Bill Passed. YEAs 50 NAYs 50 (VP tiebreaker)”
- Senate Democratic Leadershiphttps://www.democrats.senate.gov/newsroom/press-releases/majority-leader-schumer-statement-on-the-inflation-reduction-act-delivering-lower-health-care-and-prescription-drug-costs ↗
“For years politicians promised to take on the big drug companies and empower Medicare to negotiate lower drug prices for consumers. With the Inflation Reduction Act Democrats have delivered.”